Prestige Consumer Healthcare Statistics
Share Statistics
Prestige Consumer Healthcare has 49.41M shares outstanding. The number of shares has increased by -0.12% in one year.
Shares Outstanding | 49.41M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -0.24% |
Owned by Institutions (%) | n/a |
Shares Floating | 48.83M |
Failed to Deliver (FTD) Shares | 10.72K |
FTD / Avg. Volume | 4.03% |
Short Selling Information
The latest short interest is 2.37M, so 4.8% of the outstanding shares have been sold short.
Short Interest | 2.37M |
Short % of Shares Out | 4.8% |
Short % of Float | 4.87% |
Short Ratio (days to cover) | 10.3 |
Valuation Ratios
The PE ratio is 17.04 and the forward PE ratio is 17.11. Prestige Consumer Healthcare 's PEG ratio is 2.47.
PE Ratio | 17.04 |
Forward PE | 17.11 |
PS Ratio | 3.17 |
Forward PS | 3.6 |
PB Ratio | 2.15 |
P/FCF Ratio | 14.9 |
PEG Ratio | 2.47 |
Enterprise Valuation
Prestige Consumer Healthcare Inc. has an Enterprise Value (EV) of 4.49B.
EV / Earnings | 21.45 |
EV / Sales | 3.99 |
EV / EBITDA | 12.01 |
EV / EBIT | 13.12 |
EV / FCF | 18.76 |
Financial Position
The company has a current ratio of 3.2, with a Debt / Equity ratio of 0.68.
Current Ratio | 3.2 |
Quick Ratio | 2.02 |
Debt / Equity | 0.68 |
Total Debt / Capitalization | 40.61 |
Cash Flow / Debt | 0.22 |
Interest Coverage | 5.1 |
Financial Efficiency
Return on equity (ROE) is 0.13% and return on capital (ROIC) is 9.29%.
Return on Equity (ROE) | 0.13% |
Return on Assets (ROA) | 0.06% |
Return on Capital (ROIC) | 9.29% |
Revenue Per Employee | 1.97M |
Profits Per Employee | 367.26K |
Employee Count | 570 |
Asset Turnover | 0.34 |
Inventory Turnover | 3.61 |
Taxes
Income Tax | 66.69M |
Effective Tax Rate | 0.24 |
Stock Price Statistics
The stock price has increased by 37.08% in the last 52 weeks. The beta is 0.47, so Prestige Consumer Healthcare 's price volatility has been higher than the market average.
Beta | 0.47 |
52-Week Price Change | 37.08% |
50-Day Moving Average | 77.54 |
200-Day Moving Average | 71.74 |
Relative Strength Index (RSI) | 57.97 |
Average Volume (20 Days) | 266.23K |
Income Statement
In the last 12 months, Prestige Consumer Healthcare had revenue of $1.13B and earned $209.34M in profits. Earnings per share was $4.21.
Revenue | 1.13B |
Gross Profit | 624.45M |
Operating Income | 342.43M |
Net Income | 209.34M |
EBITDA | 373.86M |
EBIT | 342.43M |
Earnings Per Share (EPS) | 4.21 |
Balance Sheet
The company has $46.47M in cash and $1.14B in debt, giving a net cash position of -$1.09B.
Cash & Cash Equivalents | 46.47M |
Total Debt | 1.14B |
Net Cash | -1.09B |
Retained Earnings | 1.34B |
Total Assets | 3.32B |
Working Capital | 273.80M |
Cash Flow
In the last 12 months, operating cash flow was $248.93M and capital expenditures -$9.55M, giving a free cash flow of $239.38M.
Operating Cash Flow | 248.93M |
Capital Expenditures | -9.55M |
Free Cash Flow | 239.38M |
FCF Per Share | 4.81 |
Margins
Gross margin is 55.49%, with operating and profit margins of 30.43% and 18.6%.
Gross Margin | 55.49% |
Operating Margin | 30.43% |
Pretax Margin | 24.53% |
Profit Margin | 18.6% |
EBITDA Margin | 33.22% |
EBIT Margin | 30.43% |
FCF Margin | 21.27% |
Dividends & Yields
PBH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 5.13% |
FCF Yield | 5.9% |
Analyst Forecast
The average price target for PBH is $80, which is -2.6% lower than the current price. The consensus rating is "Buy".
Price Target | $80 |
Price Target Difference | -2.6% |
Analyst Consensus | Buy |
Analyst Count | 3 |
Scores
Altman Z-Score | 2.93 |
Piotroski F-Score | 8 |